Form 4: Apyx Medical Corp Director Baylor-Henry Acquires Stock Options

Director Minnie Baylor-Henry acquired 50,000 stock options in Apyx Medical Corp on January 15, 2025, as part of the Director Compensation Program.

Summary

• Minnie Baylor-Henry, a director of Apyx Medical Corp, acquired 50,000 stock options on January 15, 2025.
• The options were granted as part of the Issuer's Director Compensation Program.
• The exercise price of the options is $1.42.
• The options vest ratably over a 12-month period and become fully vested and exercisable on the first anniversary of the grant date.
• The options expire on January 15, 2035.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally. The grant of options can be seen as a positive sign of aligning director interests with shareholder value.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.

Industry Context

Director compensation through stock options is a common practice in publicly traded companies to incentivize performance and align director interests with shareholder value.

Comparison to Industry Standards

• Stock option grants to non-employee directors are a standard component of compensation packages in many publicly traded companies, particularly in the medical device industry.
• The vesting schedule of 12 months is also a common practice to ensure continued service and commitment from the director.

Stakeholder Impact

• The grant of stock options to a director can potentially align their interests with those of the shareholders, encouraging decisions that increase shareholder value.

Key Dates